BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36603173)

  • 1. Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity Carcinoma.
    Liu Y; Ma Y; Shayan G; Sun S; Huang X; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Xiao J; Li Y; Yi J; Wang J
    JCO Precis Oncol; 2023 Jan; 7():e2200365. PubMed ID: 36603173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio-based nomogram for prognosis evaluation and treatment optimization of non-metastatic oral cavity squamous cell carcinoma.
    Ma Y; Liu Y; Shayan G; Yi J; Wang J
    Transl Oncol; 2022 Jun; 20():101401. PubMed ID: 35339030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.
    Xie X; Kang M; Qu Z; Gu K
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17241-17251. PubMed ID: 37804427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantage of log odds of positive lymph nodes in prognostic evaluation of patients with early-onset colon cancer.
    Xia HB; Chen C; Jia ZX; Li L; Xu AM
    World J Gastrointest Surg; 2023 Nov; 15(11):2430-2444. PubMed ID: 38111780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prognostic nomograms for postoperative patients with oral cavity squamous cell carcinoma in the central region of China.
    Xu XL; Xu JH; He JQ; Li YH; Cheng H
    BMC Cancer; 2024 Jun; 24(1):730. PubMed ID: 38877437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.
    Guo Z; Wang N; Liu F; Zhao Q
    Am J Transl Res; 2022; 14(1):135-149. PubMed ID: 35173834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
    Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
    Front Oncol; 2022; 12():940601. PubMed ID: 36439411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of lymph node ratio-based nomograms for primary duodenal adenocarcinoma after surgery.
    Shi J; Liu S; Cao J; Shan S; Zhang J; Wang Y
    Front Oncol; 2022; 12():962381. PubMed ID: 36276093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram to predict cervical lymph node metastasis in head and neck squamous cell carcinoma.
    Chen X; Zhang L; Lu H; Tan Y; Li B
    Front Oncol; 2023; 13():1174457. PubMed ID: 38282669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma.
    Liu Y; Zhang J; Wang J; Wu R; Huang X; Wang K; Qu Y; Chen X; Li Y; Zhang Y; Yi J
    Radiol Oncol; 2022 Dec; 56(4):479-487. PubMed ID: 36503717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T
    Shi J; Liu S; Cao J; Shan S; Ren C; Zhang J; Wang Y
    Front Oncol; 2022; 12():899759. PubMed ID: 35574346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram-Based Prediction of Overall and Disease-Specific Survival in Patients With Postoperative Major Salivary Gland Squamous Cell Carcinoma.
    Li L; Zhang D; Ma F
    Technol Cancer Res Treat; 2022; 21():15330338221117405. PubMed ID: 35950233
    [No Abstract]   [Full Text] [Related]  

  • 15. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Hypopharyngeal Squamous Cell Carcinomas: A Population-Based Study.
    Wang J; Liu X; Tang J; Zhang Q; Zhao Y
    Front Public Health; 2021; 9():815631. PubMed ID: 35096758
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection.
    Shi X; Hu WP; Ji QH
    Oncotarget; 2017 May; 8(18):29722-29740. PubMed ID: 28430613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Survival Nomogram Containing Lymph Node Ratio for Hypopharyngeal Carcinoma Patients After Neck Dissection.
    Li F; Huang Q; Hsueh C; Huang H; Zhu Y; Gong H; Tao L; Zhou L; Zhang M
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1097-1106. PubMed ID: 36939525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
    Wang S; Yu Y; Xu W; Lv X; Zhang Y; Liu M
    BMC Cancer; 2021 Aug; 21(1):653. PubMed ID: 34344326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram to predict cancer-specific survival in patients with hypopharyngeal squamous cell carcinoma treated with primary surgery.
    Wang K; Xu X; Xiao R; Du D; Wang L; Zhang H; Lv Z; Li X; Li G
    J Int Med Res; 2021 Dec; 49(12):3000605211067414. PubMed ID: 34939432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
    Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
    Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.